Home >> Report Store >> Healthcare >> Anxiety Disorders And Depression Treatment Market Forecast to 2025 >

Anxiety Disorders Treatment Market, By Drug Category (SSRIs, TCAs, SNRIs, MAOIs, Anticonvulsants, and Others), By Therapy (TMS, ECT, CBT, and FWS), and Geography (NA, EU, APAC, and RoW) – Analysis, Share, Trends, Size, & Forecast From 2014 – 2025

100 Pages | Published Date : 25 / 07 / 17  | Report Code: AV125 | Report Format: PDF

REPORT HIGHLIGHT

The anxiety disorders market is estimated to represent a global market of USD 18,234 million by 2025 with growth rate of 2.2%.

Market Dynamics

Anxiety is defined as an excessive fear of a normal situation or an exaggerated response to a fear. Anxiety is one of the fast spreading disorder across the globe, majorly among young population. However, people often live with anxiety problem for years before they diagnose or treat with the condition which would in turn hamper the market growth to some extent. According to the American Psychiatric Association, anxiety can be categorized into phobias, acute stress disorder, panic disorder, obsessive-compulsive disorder, generalized anxiety disorder, and post-traumatic stress disorder. Increasing prevalence of anxiety related disorders has led to high clinical urgency for adoption of various therapies and therapeutics available in the market, which is anticipated to fuel growth over the coming years. As per World Health Organization (WHO), anxiety and other form of depressions are one of the most common mental disorders affecting more than 300 million people worldwide. The number is projected to increase at constant rate during the forecast period.

Drug Category Takeaway

In terms of drug category, the market is divided into Selective Serotonin Reuptake Inhibitors (SSRIs), Tricyclic Antidepressants (TCAs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Monoamine oxidase inhibitors (MAOIs), Anticonvulsants, and Others. Among which, SSRIs and SNRIs are contributed to largest market share, capturing almost 60% share of the global market. Furthermore, segments such as beta blockers, SSRIs and others are considered to be the highest growing market segment during the coming years. This upsurge is a consequence of high stress and competitive work environment coupled with unprecedented shift in the lifestyle, such as drinking, smoking, consumption of unhealthy food, etc.

Therapy Takeaway

Based on therapy category the market is analysed into Transcranial Magnetic Stimulator, Electroconvulsive Therapy (ECT), Cognitive Behaviour Therapy (CBT), Fischer Wallace Stimulator, and Others. Fischer Wallace Stimulator, and Transcranial Magnetic Stimulator are the largest revenue generating segment. Collectively, these two segment recorded over USD 1,500 million revenue and are projected to dominate the market growth during the forecast period. High efficiency coupled with increasing demand of these therapies in developed regions such as North America and Europe led the market growth.

Regional Takeaway

Regionally, developed countries of North America and Europe dominated the market, captured more than 70% share of the global market. Boost in research and development activities by key operating companies to introduce novel anxiety therapeutics and therapies coupled with surge in demand for effective anxiety therapeutics among end-users drives the market growth.

Furthermore, large number of therapeutics under clinical investigation in North America & Europe further support the market growth. For example, Switzerland based Adde Therapeutics initiated multi-centric, double-blinded, Phase II tiral of ADX71149 in adults affected with major depressive disorder in collaboration with Janssen Pharmaceuticals, Inc. These types of initiatives will support the market growth to great extent.

The market size and forecast for each segment has been provided for the period 2014 to 2025, considering 2015 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2016 to 2025 for every reported segment.

The years considered for the study are:

  • Historical Year – 2014 & 2015
  • Base Year – 2015
  • Estimated Year – 2016
  • Projected Year – 2025

TARGET AUDIENCE

  • Hospitals
  • Manufacturers
  • Traders, Distributors, And Suppliers
  • Government and Regional Agencies and Research Organizations
  • Consultants
  • Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

MARKET,BY DRUG CATEGORY

  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Tricyclic Antidepressants (TCAs)
  • Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
  • Monoamine oxidase inhibitors (MAOIs)
  • Anticonvulsants
  • Others

MARKET,BY THERAPY

  • Transcranial Magnetic Stimulator
  • Electroconvulsive Therapy (ECT)
  • Cognitive Behaviour Therapy (CBT)
  • Fischer Wallace Stimulator
  • Others

MARKET,BY REGION

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

MARKET,BY COUNTRY

  • Further Breakdown of The North America Market
    • S.
    • Canada
  • Further Breakdown of The Europe Market
    • Germany
    • France
    • Rest of Europe
  • Further Breakdown of The APAC Market
    • India
    • China
    • Rest of APAC
  • Further Breakdown of The Rest of the World Market
    • Middle East and Africa
    • Latin America

TABLE OF CONTENTS

  1. ANXIETY DISORDER TREATMENT MARKET OVERVIEW
    • Study Scope
    • Base Year
    • Assumption and Methodology
  2. EXECUTIVE SUMMARY
    • Key Market Facts
    • Geographical Scenario
    • Companies in the Market
  3. ANXIETY DISORDER TREATMENT KEY MARKET TRENDS
    • Market Drivers
      • Impact Analysis of Market Drivers
    • Market Restraints
      • Impact Analysis of Market Restraints
    • Market Opportunities
    • Market Future Trends
  4. ANXIETY DISORDER TREATMENT INDUSTRY STUDY
    • Company Activity Analysis
    • Regulatory Framework Analysis
    • Value Chain Analysis
  5. ANXIETY DISORDER TREATMENT MARKET LANDSCAPE
    • Market Share Analysis
    • Key Innovators
  6. ANXIETY DISORDER TREATMENT MARKET – BY DRUG CATEGORY:
    • Overview
    • Serotonin Reuptake Inhibitors (SSRIs)
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
    • Tricyclic Antidepressants (TCAs)
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
    • Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
    • Monoamine oxidase inhibitors (MAOIs)
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
    • Anticonvulsants
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
    • Others
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
  1. ANXIETY DISORDER TREATMENT MARKET – BY THERAPY:
    • Overview
    • Transcranial Magnetic Stimulator
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
    • Electroconvulsive Therapy (ECT)
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
    • Cognitive Behaviour Therapy (CBT)
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
    • Fischer Wallace Stimulator
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
    • Others
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
  1. ANXIETY DISORDER TREATMENT MARKET– BY GEOGRAPHY
    • Introduction
    • North America
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
      • U.S.
        • Overview
        • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
      • Canada
        • Overview
        • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
      • Europe
        • Overview
        • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
        • France
          • Overview
          • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
        • Germany
          • Overview
          • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
        • Rest of Europe
          • Overview
          • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
        • Asia Pacific (APAC)
          • Overview
          • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
          • China
            • Overview
            • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
          • India
            • Overview
            • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
          • Rest of APAC
            • Overview
            • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
          • Rest of the World
            • Overview
            • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
            • Latin America
              • Overview
              • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
            • Middle East and Africa
              • Overview
              • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
  1. KEY VENDOR ANALYSIS
    • Eli Lily & Company
      • Company Overview
      • SWOT Analysis
      • Key Developments
    • Bristol-Myers Squibb Company
      • Company Overview
      • SWOT Analysis
      • Key Developments
    • AstraZeneca plc
      • Company Overview
      • SWOT Analysis
      • Key Developments
    • Johnson & Johnson
      • Company Overview
      • SWOT Analysis
      • Key Developments
    • GlaxoSmithKline
      • Company Overview
      • SWOT Analysis
      • Key Developments
    • Pfizer, Inc.
      • Company Overview
      • SWOT Analysis
      • Key Developments
  1. 360 DEGREE ANALYSTVIEW
  2. APPENDIX
    • Research Methodology
    • Abbreviations
    • Disclaimer
    • Contact Us

SCOPE AND OBJECTIVES

The objective of this report is to describe the market trends and revenue forecasts for the ANXIETY DISORDER TREATMENT Market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the coil coatings market. The scope of this report covers the ANXIETY DISORDER TREATMENT Market by its major segments, which include the type, end user industry, and the major geographic regions.

KEY BENEFITS OF THE REPORT:

  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Extensive analysis of the key players dominating the competitive landscape of this market
  • In-depth analysis of the key factors are propelling the growth of the global market
  • Detailed analysis of the geographic region that will witness the strongest growth
  • Granular analysis of the current market scenario and the expected market grow
RESEARCH METHDOLOGY

AnalystView’s research methodology is developed on a combination of specialist industry analyst knowledge and in-country research experience. We employ data interrogation methodologies to generate new and meaningful analyses and insights. The research study involves extensive usage of secondary sources, directories, and databases (such as Hoovers, Bloomberg, and Businessweek) to identify and collect information useful to understand technical, market-oriented, and commercial aspects of market. Market data and information are also collected and not limited to secondary sources like:

  • Official Company’s Website, Financial and Annual Reporting
  • Government Statistical Data
  • Online Publishing Articles
  • Industry Player’s Investor Presentations
  • Economic News Articles
  • National and International Trade Associations
  • The Financial, Business and Mainstream Press
  • Industry Study Groups and Other Semi-Official Sources
  • Many Other Informative Channels Related to the Market Topics
  • Gathering data through secondary sources is only the first step. The ability to cross-refer market data through available secondary information often conflicting across multiple sources is a key aspect of the added value we provide

In order to verify and validate secondary market data, we engage with a variety of personnel in key players at all points through phone calls, emails and web based survey responses with key opinion leaders (KoL’s) operating in the respective markets. The engagement involves the CEO, vice presidents, top-level and middle-level managers of the company, directors of marketing, product managers, brand managers, customers of major industrial products, and many others. We also interview manufacturers, distributors, materials suppliers, retailers, service operators, study groups, industry associations, and third party observers from the trade and financial press. These obtained information helped us to understand several facets of the market with respect to manufacturers’ and buyers’ perspective. These data were carefully filtered, analyzed, compared and presented in an easy way to develop accurate research study. Furthermore, all collected data is subjected to undergo exhaustive review process at country level, regional level and global level.

MARKET FORECAST

Market forecast for the respective market is primarily based on the year on year (YOY) growth rate. Data projection and future performance of each segment analyzed based on the key aspects extracted from primary and secondary research results. Thus data projection states the assumption on how the market behaves under macroeconomic and microeconomic parameters. Our market forecasting represents strategic conclusion we have reached about the coming state of the market scenario.

MARKET ANALYSIS

Another integral part of our research study is that AnalystView’s market data is accompanied by clear written analysis. We include detail information on market segments in terms of market drivers, market restraints and market opportunities. These offer insights of different channel dynamics, brand preference, incidence/prevalence data, technology up gradation, consumption trend, and future market scenario. We also include supporting data with any relevant awareness campaign, new introduction, regulatory norms, government initiatives, and industry player’s expansion in specific product segments. From research perspective, this information explains and substantiates estimated data finding and forecast.

Why AnalystView

Z

Trusted Partnership

We strive to become one of the trusted partner of our client by offering value added services and concrete research data.

Y

Tailor Made Solutions

From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round our client’s exact needs.

Turnaround Time

Our analyst aims to provide research studies in quickest turnaround time and in a much cost effective manner.

T

Data Accuracy And Reliablity

We utilize a mix of primary, secondary research, and machine learning algorithms to generate accurate and comprehensive data about market size and revenue forecasts.

Competitive Pricing

We offer most competitive pricing policy across the research industry

Client Testimonials

 

Asia Pacific based Chemical Industry (Privacy Requested)

Thanks AnalystView for putting a great team to work on our research projects. It was a smooth transition of knowledge and delivery was seamless. We are keen to work with you on our upcoming projects. Thank you once again for the professional attitude your team has demonstrated.

CEO, Europe based Digital Media Company (Privacy Requested)

We had confusion after receiving the final data sheet of report. As per some preliminary we already have, we believe the market is over estimated.. However, after string of calls with analyst, we found their final research analysis was methodologically sound and their work to be very professional and up […]

Managing Director, Chemical based Company, Asia Pacific (Privacy Requested)

We are happy with the way the AnalystView member understood the brief and went about executing our research project.

U.S. Headquartered Medical Device Company (Privacy Requested)

AnalystView team has done brand assessment study for blood glucose monitoring devices market, in which we want enter into….We were very impressed not only by their research skills but also by their understanding of issues relevant to our requirements…!!

Vice President, Petrochemical Firm based in China (Privacy Requested)

It was a pleasure assigning project to AnalystView; they are reliable, fast and friendly. Highly recommend this company for research workJGood stuff!

US based healthcare service provider (Privacy Requested)

Frankly, we didn’t expect much comprehensive data for the report we purchased. To be surprised, I must say the report we received was very nicely executed….It contains all the information we are looking for and satisfied with the quality of the report. Thank you team

Europe based Chemical Industry (Privacy Requested)

Just wanted to say massive thanks for all the help from the AnalystView team. We purchased two reports one is Food Safety Testing report and another one is Enzyme market. These reports have helped us build a sound knowledge base of our business segments and have taken our business to […]

Why Choose Us

 

We devise research report with quality data:

Combined with an in-depth knowledge of the current industry and a sharp analytical mind, AnalystView serve our customer accurate research in accordance with a constantly evolving industry.

We work with businesses just like yours: 

AnalystView committed to making a positive difference for our clients. This means whatever you demand, chances are we already have experience with something similar.

Share This